Securian Asset Management Inc. Sells 200 Shares of Henry Schein, Inc. $HSIC

Securian Asset Management Inc. decreased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 3.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,334 shares of the company’s stock after selling 200 shares during the quarter. Securian Asset Management Inc.’s holdings in Henry Schein were worth $463,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its position in Henry Schein by 6.5% in the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock worth $436,489,000 after buying an additional 390,399 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Henry Schein by 4.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock worth $153,480,000 after buying an additional 103,384 shares during the last quarter. Burgundy Asset Management Ltd. lifted its position in Henry Schein by 33.9% in the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock worth $153,105,000 after buying an additional 566,530 shares during the last quarter. Clarkston Capital Partners LLC lifted its position in Henry Schein by 0.4% in the 1st quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company’s stock worth $119,965,000 after buying an additional 7,345 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Henry Schein by 1.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company’s stock worth $82,440,000 after buying an additional 11,999 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $63.84 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The company has a market cap of $7.74 billion, a PE ratio of 20.59, a P/E/G ratio of 2.10 and a beta of 0.81. The business has a 50 day moving average of $66.73 and a 200 day moving average of $68.53. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein’s revenue was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Ratings Changes

HSIC has been the subject of a number of recent research reports. Leerink Partners set a $75.00 target price on Henry Schein in a research report on Monday, July 14th. JPMorgan Chase & Co. lowered their price objective on Henry Schein from $80.00 to $76.00 and set an “overweight” rating for the company in a research report on Thursday, August 7th. Baird R W downgraded Henry Schein from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 14th. Weiss Ratings reiterated a “hold (c)” rating on shares of Henry Schein in a research report on Wednesday, October 8th. Finally, Evercore ISI upgraded Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price objective for the company in a research report on Tuesday, August 26th. Five investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.